MedPath
FDA Approval

POSACONAZOLE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 7, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Posaconazole(100 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

ATLANTIC BIOLOGICALS CORP.

ATLANTIC BIOLOGICALS CORP.

047437707

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

POSACONAZOLE

Product Details

NDC Product Code
17856-2133
Application Number
ANDA212411
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 1, 2022
HYPROMELLOSE ACETATE SUCCINATE 12070923 (3 MM2/S)Inactive
Code: 36BGF0E889Class: IACT
Code: 6TK1G07BHZClass: ACTIBQuantity: 100 mg in 1 1
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5PClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
HYDROXYPROPYL CELLULOSE (1200000 WAMW)Inactive
Code: U3JF91U133Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath